Literature DB >> 26850923

Comparative analysis of dual-phase 18F-fluoride PET/CT and three phase bone scintigraphy in the evaluation of septic (or painful) hip prostheses: A prospective study.

Rajender Kumar1, Rakesh Kumar1, Vijay Kumar2, Rajesh Malhotra3.   

Abstract

BACKGROUND: The preoperative differentiation of aseptic and septic loosening of hip prostheses remains a diagnostic challenge for clinicians and many molecular imaging techniques have been evaluated. The objective of current study was to establish the clinical utility of dual phase 18F-fluoride PET/CT (DPFP) in diagnosing implant loosening, differentiation between septic and aseptic loosening and to compare the diagnostic accuracy of DPFP and three-phase bone scan (TPBS).
METHODS: In this prospective study, we evaluated 57 hip components in 45 patients (bilateral prostheses in 12 patients, 45 painful and 12 asymptomatic contralateral hip components) with dual phase fluoride PET/CT and TPBS. Findings of skeletal scintigraphy and PET/CT were evaluated by two expert nuclear medicine physicians, blinded with clinical findings and final diagnosis. The patterns of tracer uptake and maximum standardized uptake value (SUVmax) were noted for each joint. The final diagnosis was based on intraoperative findings, histopathological or microbiological examinations.
RESULTS: Out of twelve non-painful hips, DPFP correctly identified no loosening in 11 hips while TPBS detected in 10 hips. In the remaining 45 hips with radiological proven loosening to rule out sepsis, DPFP had a sensitivity, specificity, PPV, NPV and accuracy of 75%, 97%, 92%, 88% and 88% respectively while TPBS revealed 81%, 86%, 76%, 89% and 82% respectively. DPFP had shown a higher specificity and PPV as compared to the TPBS in the evaluation of painful hip prostheses. The pattern of tracer uptake may help in the differentiation between the two entities. We also noted a significant difference between SUVmax values of septic and aseptic loosening.
CONCLUSIONS: The results suggested that DPFP has considerable potential in differentiating septic from aseptic loosening of hip prostheses and more specific to rule out sepsis than TPBS. It may be employed before revision arthroplasty to evaluate implant for loosening and sepsis in loosened implant.
Copyright © 2016 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26850923     DOI: 10.1016/j.jos.2015.12.018

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  5 in total

1.  Clinical value of dual-phase F-18 sodium fluoride PET/CT for diagnosing bone metastasis in cancer patients with solitary bone lesion.

Authors:  Jeong Won Lee; Yong-Jin Park; Youn Soo Jeon; Ki Hong Kim; Jong Eun Lee; Sung Hoon Hong; Sang Mi Lee; Su Jin Jang
Journal:  Quant Imaging Med Surg       Date:  2020-11

2.  Application of 68Ga-citrate PET/CT for differentiating periprosthetic joint infection from aseptic loosening after joint replacement surgery.

Authors:  Tingting Xu; Yalan Zeng; Xiao Yang; Guangfu Liu; Taiyong Lv; Hongbin Yang; Fei Jiang; Yue Chen
Journal:  Bone Joint Res       Date:  2022-06       Impact factor: 4.410

Review 3.  A Systematic Review and Meta-Analysis on the Accuracy of Fluorodeoxyglucose Positron Emission Tomography/ Computerized Tomography for Diagnosing Periprosthetic Joint Infections.

Authors:  Mei Hu; Guangwen Chen; Lin Luo; Lan Shang
Journal:  Front Surg       Date:  2022-06-01

4.  Clinical application of dual-phase F-18 sodium-fluoride bone PET/CT for diagnosing surgical site infection following orthopedic surgery.

Authors:  Jeong Won Lee; Shi Nae Yu; Ik Dong Yoo; Min Hyok Jeon; Chang-Hwa Hong; Jai-Joon Shim; Sung-Hae Chang; Sang Mi Lee
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

5.  Case Report of a Diagnosed Septic Hip Joint Treated with a 2-Stage Hip Arthroplasty.

Authors:  Jesse A Raszewski; A D Hoffman; H B Bamberger; A G Manocchio
Journal:  J Orthop Case Rep       Date:  2021-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.